₹ 0.3 Cr
Volume Transacted
(Dec 27, 2024)
1.7 K
Stocks Traded
(Dec 27, 2024)
Last Updated on: Dec 27, 2024
Ipca Laboratories Ltd
NSE: IPCALAB
EPS
₹ 26.47
Last updated on: Dec 26, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Historical Earning per Share of Ipca Laboratories Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
No data available
* All values are in ₹
Market Cap
₹ 40,423 Cr
EPS
₹ 26.5
P/E Ratio (TTM) *
60.2
P/B Ratio (TTM) *
6.0
Day’s High *
1612.5
Day’s Low
₹ 1589.15
DTE *
0.2
ROE *
9.9
52 Week High
₹ 1708.7
52 Week Low
₹ 1053.45
ROCE *
14.0
* All values are consolidated
Last Updated time: 27 Dec 10:45 AM
* All values are consolidated
Last Updated time: 27 Dec 10:45 AM
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
26 Dec 2024 | 1593.35 | 1584.5 | 1600.8 | 1568.25 |
24 Dec 2024 | 1582.25 | 1582.6 | 1624.9 | 1573.2 |
23 Dec 2024 | 1585.6 | 1599.4 | 1602.8 | 1568.8 |
20 Dec 2024 | 1584.25 | 1608 | 1616.8 | 1578.6 |
19 Dec 2024 | 1593.45 | 1482.8 | 1602 | 1476.75 |
18 Dec 2024 | 1516.05 | 1582.45 | 1592.95 | 1494.85 |
17 Dec 2024 | 1557.8 | 1564.7 | 1580.8 | 1554.5 |
16 Dec 2024 | 1564.9 | 1539.35 | 1569.5 | 1532.35 |
13 Dec 2024 | 1534.55 | 1554.95 | 1563.3 | 1530.9 |
12 Dec 2024 | 1559.95 | 1574.95 | 1574.95 | 1555 |
Date | Price (₹) |
---|---|
26 Dec 2024 | 1593.35 |
24 Dec 2024 | 1582.25 |
23 Dec 2024 | 1585.6 |
20 Dec 2024 | 1584.25 |
19 Dec 2024 | 1593.45 |
18 Dec 2024 | 1516.05 |
17 Dec 2024 | 1557.8 |
16 Dec 2024 | 1564.9 |
13 Dec 2024 | 1534.55 |
12 Dec 2024 | 1559.95 |
Strength
2
S
Weakness
4
W
Opportunity
0
O
Threats
1
T
Revenue
Profitability
Affordability
Liquidity
Dividend
Market Value
₹ 40,424
Asset Value
₹ 5,103
6.9 X
Value addition
* All values are in Rupees
Company Name | EPS | Market Cap (INR Cr.) |
---|---|---|
Ipca Laboratories Ltd | 26 | 40,423 |
Sun Pharmaceuticals Industries Ltd | 46 | 4,41,838 |
Divis Laboratories Ltd | 69 | 1,56,107 |
Cipla Ltd | 57 | 1,20,270 |
Mankind Pharma Ltd | 51 | 1,20,212 |
Torrent Pharmaceuticals Ltd | 51 | 1,15,638 |
Historical Market Cap of Ipca Laboratories Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
No data available
* All values are in ₹ crore
Historical Revenue of Ipca Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical EBITDA of Ipca Laboratories Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
No data available
* All values are in ₹ crore
Historical Net Profit of Ipca Laboratories Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
No data available
Ipca Laboratories to voluntarily close its wholly owned subsidiary in Mexico
Ipca Laboratories has received necessary approval for voluntary closure of its wholly owne...
04 Dec 2024 16:57
Ipca Laboratories Ltd up for third straight session
Ipca Laboratories Ltd gained for a third straight session today. The stock is quoting at R...
19 Nov 2024 13:05
Board of Ipca Laboratories recommends Interim Dividend
Ipca Laboratories announced that the Board of Directors of the Company at its meeting held...
14 Nov 2024 15:29
Ipca Labs rises as Q2 PAT climbs 58% YoY to Rs 229 cr
Profit before tax surged 53.01% to Rs 344.83 crore in the September 2024 quarter from Rs 2...
14 Nov 2024 14:54
Ipca Laboratories schedules board meeting
Ipca Laboratories will hold a meeting of the Board of Directors of the Company on 14 Novem...
25 Oct 2024 11:15
Board of Ipca Laboratories approves consolidation of USA generic formulations biz
The Board of Ipca Laboratories at its meeting held on 30 September 2024 has approved enter...
30 Sep 2024 18:44
Concalls
June 2024
TranscriptFeb 2024
TranscriptNov 2023
TranscriptAug 2023
TranscriptApr 2023
TranscriptFeb 2023
TranscriptNov 2022
TranscriptAug 2022
TranscriptMay 2022
TranscriptFeb 2022
TranscriptNov 2021
TranscriptAug 2021
TranscriptJune 2021
TranscriptMar 2021
TranscriptNov 2020
TranscriptAug 2020
TranscriptJune 2020
TranscriptFeb 2020
TranscriptJune 2024
TranscriptFeb 2024
TranscriptNov 2023
TranscriptAug 2023
TranscriptApr 2023
TranscriptFeb 2023
TranscriptNov 2022
TranscriptAug 2022
TranscriptMay 2022
TranscriptFeb 2022
TranscriptNov 2021
TranscriptAug 2021
TranscriptJune 2021
TranscriptMar 2021
TranscriptNov 2020
TranscriptAug 2020
TranscriptJune 2020
TranscriptFeb 2020
TranscriptUnlimited trading starting at just Rs. 249*